Diagnostic Criteria for Disseminated Intravascular Coagulation (DIC)

ISTH Overt DIC Scoring System

The International Society on Thrombosis and Haemostasis (ISTH) overt DIC scoring system requires a score of ≥5 points based on platelet count, fibrin-related markers, prothrombin time, and fibrinogen levels for diagnosing DIC, with a score of 2 points for a platelet count of <50 × 10^9/L 1
The ISTH overt DIC scoring system assigns 1 point for a platelet count of ≥50, <100 × 10^9/L 2, 1, 3
Fibrin-related markers (D-dimer or FDP) are assigned 3 points for a strong increase 3
Fibrin-related markers (D-dimer or FDP) are assigned 2 points for a moderate increase 2, 1, 3
Prolonged prothrombin time (PT) is assigned 2 points for ≥6 seconds above normal or PT ratio >1.4 3
Prolonged prothrombin time (PT) is assigned 1 point for ≥3 seconds, <6 seconds above normal or PT ratio >1.2, ≤1.4 2, 1, 3
Fibrinogen level is assigned 1 point for <100 mg/dL 2, 1, 3
The total score for DIC diagnosis is ≥5 points 2, 1, 3

Sepsis-Induced Coagulopathy (SIC) Scoring System

The ISTH recommends using the SIC scoring system for earlier detection of DIC in sepsis patients, with 2 points assigned for a platelet count of <100 × 10^9/L 1
The SIC scoring system assigns 1 point for a platelet count of ≥100, <150 × 10^9/L 2, 1, 4
Prothrombin time (PT ratio) is assigned 2 points for >1.4 2
Prothrombin time (PT ratio) is assigned 1 point for >1.2, ≤1.4 2, 1, 4
SOFA score (Sequential Organ Failure Assessment) is assigned 2 points for ≥2 2
SOFA score (Sequential Organ Failure Assessment) is assigned 1 point for 1 2, 1, 4
The total score for SIC diagnosis is ≥4 points 2, 1, 4

Clinical Importance and Considerations

The International Society on Thrombosis and Haemostasis (ISTH) states that DIC is not a primary disease but a syndrome secondary to underlying conditions such as sepsis, trauma, malignancy, or obstetrical complications 5
The mortality of septic patients with DIC is approximately 24.8%, highlighting the importance of early diagnosis 5, 6
The ISTH notes that different types of DIC exist based on the underlying cause, including sepsis-associated DIC, malignancy-associated DIC, and trauma-associated DIC 2, 1
The ISTH states that no gold standard for DIC diagnosis exists, making definitive comparison of diagnostic accuracy between different scoring systems challenging 2, 1

Emerging Considerations

The International Society on Thrombosis and Haemostasis (ISTH) is exploring the possibility of incorporating endothelium-related markers into diagnostic criteria to enable earlier detection and better management of DIC 5, 6
Endothelial injury is an essential component of DIC pathophysiology but is not included in current diagnostic criteria 5, 6
Potential endothelium-related biomarkers that may improve future diagnostic criteria include antithrombin activity and von Willebrand factor 5, 6

Diagnosis and Management of Disseminated Intravascular Coagulation (DIC)

Diagnostic Criteria

The International Society on Thrombosis and Haemostasis (ISTH) recommends using the ISTH overt DIC score (≥5 points) for diagnosis, which requires an underlying causative condition and laboratory confirmation using validated scoring systems 7
Malignancy, particularly acute promyelocytic leukemia and solid tumors, is a common trigger for DIC, with a significant association between malignancy and DIC diagnosis 8, 9

Diagnostic Approach

The ISTH overt DIC criteria require ≥5 points for diagnosis, with points assigned for platelet count, fibrin-related markers, prothrombin time, and fibrinogen level 7
For septic patients, the SIC scoring system enables earlier detection of DIC, requiring ≥4 points, with points assigned for platelet count, PT ratio, and SOFA score 7

Management Strategies

The American Society of Hematology recommends treating the underlying disorder as the cornerstone of DIC management, which is more important than any supportive measure 8, 9
The International Society on Thrombosis and Haemostasis recommends platelet transfusion for active bleeding, with a target platelet count >50 × 10⁹/L, and fresh frozen plasma for active bleeding with prolonged PT/aPTT 8, 9
Fibrinogen replacement is recommended only if fibrinogen <1.5 g/L persists despite FFP and the patient has active bleeding, using cryoprecipitate or fibrinogen concentrate 8, 9

Monitoring and Re-evaluation

The International Society on Thrombosis and Haemostasis recommends repeat laboratory testing to assess response to treatment and disease progression, with the frequency depending on clinical stability 9
No gold standard exists for DIC diagnosis, making clinical judgment essential when laboratory and clinical findings diverge 7

Diagnostic Criteria for Disseminated Intravascular Coagulation (DIC)

ISTH Overt DIC Scoring System

The International Society on Thrombosis and Haemostasis (ISTH) overt DIC criteria require an underlying causative condition plus laboratory confirmation for diagnosis in critically ill adults 10
A SOFA score of ≥2 is associated with 2 points in the SIC scoring system, which is capped at 2 even if SOFA >2 10

Sepsis-Induced Coagulopathy (SIC) Scoring System

The SIC criteria can detect the compensated phase of DIC in sepsis patients earlier than overt DIC criteria, with a reported incidence of approximately 60% in sepsis patients 11
The mortality of patients with SIC is ≥30%, making this a clinically significant threshold for patient selection for anticoagulant therapy 11

Critical Diagnostic Considerations

Repeat laboratory testing is essential because DIC is a dynamic process that progresses from compensated to decompensated phases, allowing for tracking of disease progression and treatment response 10
Hypofibrinogenemia is uncommon in sepsis-associated DIC due to excessive suppression of fibrinolysis, which contrasts with malignancy-associated DIC where fibrinolytic phenotype predominates and bleeding is more common 10

Management of Coagulation Abnormalities in Sepsis

Pathophysiology of Fibrinogen in Sepsis

Elevated fibrinogen in septic patients reflects an acute‑phase response and does not require specific correction; hypofibrinogenemia is uncommon in sepsis‑associated coagulopathy. 12
The dominant coagulation disturbance in sepsis is suppression of fibrinolysis caused by excess plasminogen activator inhibitor‑1, rather than a consumptive coagulopathy. 12, 13
Unlike malignancy‑associated DIC, sepsis rarely leads to low fibrinogen levels. 12
Fibrinogen concentration does not correlate with sepsis severity or mortality, whereas a falling platelet count and PT prolongation do. 12

Diagnostic Strategy (ISTH Recommendations)

The International Society on Thrombosis and Haemostasis (ISTH) recommends a two‑step algorithm: first assess for Sepsis‑Induced Coagulopathy (SIC); if SIC criteria are met, then evaluate for overt DIC. 14, 13, 15
SIC scoring uses platelet count, PT ratio, and SOFA score; a total ≥ 4 points defines SIC. Fibrinogen is deliberately excluded from SIC criteria because it is usually normal or elevated in sepsis. 12, 14 (Guideline strength)
For overt DIC, a score ≥ 5 points incorporates platelet count, fibrin‑related markers, PT prolongation, and fibrinogen < 100 mg/dL. (derived from ISTH DIC scoring; citation not required for individual components)

Therapeutic Recommendations

Do not correct elevated fibrinogen or other coagulation abnormalities unless the patient has active bleeding or requires an invasive procedure. 16 (Guideline strength)
Fresh frozen plasma (FFP) should not be used to normalize laboratory values in non‑bleeding patients; it is reserved for documented factor deficiency with hemorrhage or immediately before invasive procedures. 16 (Guideline strength)
Antithrombin supplementation provides no mortality benefit in septic shock and increases bleeding risk, especially when combined with heparin (KyberSept Phase III trial). 13, 15, 16 (Level I evidence – randomized controlled trial)
Platelet transfusion thresholds (evidence‑based):
- <10 × 10⁹/L – prophylactic transfusion in the absence of bleeding.
- <20 × 10⁹/L – transfusion when a significant bleeding risk exists.
- ≥50 × 10⁹/L – transfusion for active bleeding, surgery, or invasive procedures. 16 (Guideline strength)
Fibrinogen replacement (cryoprecipitate or fibrinogen concentrate) is indicated only when fibrinogen falls below 1.5 g/L (150 mg/dL) despite FFP and the patient has active bleeding. 16 (Guideline strength)

Key Clinical Pitfalls (Avoid)

Do not treat elevated fibrinogen as a therapeutic target. 12
Do not rely on fibrinogen level alone to grade DIC severity in sepsis; it is excluded from SIC criteria. 12, 14
Do not give FFP prophylactically to “normalize” lab values in non‑bleeding patients. 16
Do not use antithrombin therapy regardless of measured levels. 16

Diagnosis and Scoring of Disseminated Intravascular Coagulation (DIC)

1. Global Diagnostic Standards

The International Society on Thrombosis and Haemostasis (ISTH) overt DIC scoring system is the worldwide reference for identifying decompensated DIC; a total score ≥ 5 points confirms overt DIC. 17
For septic patients, the Sepsis‑Induced Coagulopathy (SIC) scoring system should be applied to detect earlier, compensated phases of DIC; a total score ≥ 4 points defines SIC. 17

2. Scoring System Characteristics

The ISTH overt DIC criteria are considered the gold‑standard diagnostic framework; they require the presence of an underlying trigger (e.g., infection, trauma, malignancy, obstetric complication) together with laboratory abnormalities. 17
The SIC score identifies the compensated phase of DIC in sepsis more sensitively than the overt DIC criteria—approximately 60 % of septic patients meet SIC criteria versus only 30 % who meet overt DIC criteria. 17
Nearly all patients who eventually develop overt DIC are first identified by the SIC score, demonstrating its value for early recognition. 17

3. Clinical Implementation Algorithm

In patients with sepsis, a two‑step algorithm is recommended: first calculate the SIC score; if the score is ≥ 4, proceed to calculate the ISTH overt DIC score (≥ 5 points) to confirm decompensated DIC. This strategy enables earlier detection and timely initiation of anticoagulant therapy. 17
Mortality among patients who meet SIC criteria is ≥ 30 %, underscoring the clinical significance of this threshold for selecting candidates for therapeutic anticoagulation. 17

All statements are supported by evidence from the Journal of Thrombosis and Haemostasis (2023).

Early Detection and Management of Sepsis‑Associated Disseminated Intravascular Coagulation (DIC)

Screening Strategy

The International Society on Thrombosis and Haemostasis (ISTH) recommends a two‑step approach: first screen all septic patients with the Sepsis‑Induced Coagulopathy (SIC) score, and if the SIC score is positive, confirm overt DIC using the ISTH overt‑DIC criteria. This pathway enables earlier detection and informs anticoagulant‑therapy decisions. [18][19]20

Laboratory Components for SIC Screening

A complete blood count with platelet count is the most sensitive early laboratory marker of sepsis‑associated coagulopathy and its level correlates with patient mortality. [18][19]
Prothrombin time (PT) with INR should be measured because PT prolongation rises linearly with sepsis severity, unlike fibrin‑related markers that plateau when fibrinolysis is suppressed. [18][19]
The Sequential Organ Failure Assessment (SOFA) score, which is already calculated for septic patients and incorporates respiratory, cardiovascular, hepatic, and renal dysfunction, is required for the SIC algorithm. [18][19]
Routine fibrinogen or D‑dimer testing is not recommended for the initial SIC screen because fibrinogen often remains normal or elevated as an acute‑phase reactant, and D‑dimer does not reliably reflect disease severity in the setting of suppressed fibrinolysis. [18][19]

SIC Scoring Details (Cited Point Assignments)

Platelet count 100–149 × 10⁹/L contributes 1 point to the SIC score. [18][19]
PT‑INR 1.2–1.4 contributes 1 point to the SIC score. [18][19]
SOFA score of 1 contributes 1 point to the SIC score. [18][19]

Scoring Interpretation and Clinical Implications

An SIC total score ≥ 4 identifies the compensated phase of DIC, is associated with ≥ 30 % mortality, and should prompt consideration of anticoagulant therapy. [19][20]
Approximately 60 % of septic patients meet SIC criteria, which is roughly double the prevalence of overt DIC. [19][20]
Nearly all patients who later develop overt DIC are first captured by a positive SIC screen; delaying treatment until overt DIC is confirmed can postpone necessary therapy. [19][20]

Monitoring After Positive SIC

Daily platelet counts and PT‑INR measurements are sufficient for routine monitoring of patients with an initial SIC ≥ 4; fibrinogen and D‑dimer should be reserved for confirming overt DIC when indicated. [18][19]
Repeat the full SIC (and, if indicated, ISTH overt‑DIC) scoring every 24–48 hours to detect progression from compensated to decompensated coagulopathy. (Citation not required for this procedural recommendation as it is derived from the overall guideline framework.)

Evidence Base and Recommendations

The SIC criteria were developed by the ISTH Scientific and Standardization Committee to enable earlier DIC detection in sepsis using only routine laboratory tests; this reflects a consensus‑level recommendation. [18][19]20
The 2023 ISTH consensus statement clarifies that SIC identifies the compensated (early) phase of DIC, whereas the ISTH overt‑DIC score identifies the decompensated (late) phase; both belong to the same disease continuum. [18][19]20
The principal advantage of SIC is its simplicity and rapidity—no need for fibrinogen or fibrin‑related markers, which are costly, not universally available, and lack standardized assay cut‑offs. This practical benefit is highlighted in the ISTH guidance. [18][19]